| 195.47 Delayed Data As of Sep 13 |  +1.47 / +0.76%Today’s Change | 166.30 Today|||52-Week Range 211.90 | +0.41% Year-to-Date |
| Previous close | 194.00 |
| Today’s open | 194.41 |
| Day’s range | 194.33 - 196.67 |
| Volume | 2,428,846 |
| Average volume (3 months) | 3,046,448 |
| Market cap | $117.2B |
| Earnings growth (last year) | +368.59% |
| Earnings growth (this year) | -0.70% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +4.32% |
| P/E ratio | 15.5 |
| Price/Sales | 5.45 |
| Price/Book | 9.85 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +0.16 | +0.24% |
| ILMNIllumina Inc | +3.39 | +1.14% |
| BIIBBiogen | +4.32 | +1.86% |
| EXASExact Sciences Corp | -1.98 | -1.82% |
| Next reporting date | October 31, 2019 |
| EPS forecast (this quarter) | $3.49 |
| Annual revenue (last year) | $23.8B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert A. Bradway |
Executive Vice President- Operations Esteban Santos |
Corporate headquarters Thousand Oaks, California |
